Introduction
Inorganic polyphosphate [Poly(P)] is a linear polymer consisting of tens to hundreds of orthophosphate residues linked by high-energy phosphoanhydride bonds. In mammals, Poly(P) is found in erythrocytes and cells of the brain, heart, lung, and liver (1) (2) (3) (4) . The most researched and well-known role of Poly(P) is in the promotion of intracellular calcification (5) . Because Poly(P) induces alkaline phosphate (ALP) activity and up-regulates osteopontin (OP) and osteocalcin (OC) gene expression (6) , Poly(P) is thought to play an important role in the maturation of bone-related immature cells, and may be involved in the construction of bone tissue by osteoblasts.
In addition to blood vessels and nerves, fibroblasts are a significant component of dental pulp tissue (7) and thus might represent a novel therapeutic target for treating pulpitis. However, the effect of Poly(P) regulation of differentiation on dental pulp fibroblastlike cells (DPFCs) has not been well defined.
Matrix metalloproteinase (MMP)-3 and interstitial collagenase (MMP-1) are produced by fibroblasts in response to increased levels of inflammatory cytokines in dental pulp injury and diseases such as periodontitis and rheumatoid arthritis (8, 9) . MMP-3 has been implicated in the joint and soft-tissue destruction associated with these conditions, where it participates in the inflammatory response (10) (11) (12) (13) (14) . MMP-3 synthesis is tightly controlled in vivo (13, 15) . Our previous study reported that proinflammatory cytokine-induced MMP-3 actually accelerates wound healing following dental pulp injury (16) (17) (18) and promotes cell proliferation (17, 19, 20) .
Recently, roles of Poly(P) have been suggested in apoptosis and modulation of the mineralization process in bone tissue (21, 22) . We previously reported that Poly(P) induces MMP-3-mediated proliferation of odontoblast-like cells derived from induced pluripotent stem cells (23) . Although we previously reported that Poly(P)-induced MMP-3-mediated proliferation of rat DPFCs is mediated by a Wnt5 signaling cascade (24) , it is unknown whether Poly(P) is associated with differentiation. Therefore, we investigated the physiological effect of Poly(P) on DPFC differentiation in vitro. We reveal a novel role of Poly(P) in the regulation of MMP-3 activity during the differentiation of osteogenic cells from DPFCs.
Materials and Methods

Materials
Type-65 Poly(P) with an average chain length of 65 phosphate residues was prepared from sodium tripolyphosphate (Taihei Chemical Industrial Co., Ltd., Osaka, Japan). Concentrations of Poly(P) are shown in terms of phosphate residues (25) . As a control, sodium phosphate buffer (pH 6.9) was used instead of Poly(P).
Cell culture
The study protocol (No. 63) was reviewed and approved by the Animal Experimentation Committee, School of Dentistry, Aichi Gakuin University, Japan. DPFCs were isolated from rat incisors and cultured using a previously described protocol (20) . The proportion of plateletderived growth factor receptor (PDGFR)-α positive cells in the total fibroblast-like cell population is a measure of the purity of DPFCs (24) . Therefore, using flow cytometry, we evaluated the ratio of PDGFR-α-positive cells as a percentage of the total differentiated cells to determine the purity of the differentiated cell population. Our DPFC cultures showed 98.64 ± 5.2% homogeneity (% total, n = 3). In all experiments, DPFCs were used at passages 2-5. Cells were seeded into six-well tissue culture plates at a density of 1 × 10 5 cells/cm 2 . To expose the cells to Poly(P), the culture medium was replaced with alpha-minimal essential medium containing 10% fetal bovine serum and Poly(P), followed by 7 days of culture.
Functional assay for assessment of the osteogenic phenotype
To assess the phenotype of the cultured cells, we measured ALP activity and calcification (as a marker of differentiation). ALP activity was determined using an ALP Staining Kit (Primary Cell Co., Ltd., Hokkaido, Japan). Mineralization from the Poly(P)-treated cells was quantified using an Alizarin red S (ARS) assay (Sigma-Aldrich, St. Louis, MO, USA). ARS staining was quantified using a previously reported method (26) and photographed using a BZ-9000 microscope (Keyence, Osaka, Japan) and/or an IN Cell Analyzer 2000 (GE Healthcare UK Ltd, Buckinghamshire, England). ; rat MMP-9: Rn00579162_m1; rat MMP-13: Rn01448194_m1). The standard curve method was used to determine the relative quantification of gene expression with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 18S rRNA as controls. Analysis was performed by the delta-delta Ct method.
Real-time quantitative polymerase chain reaction (qRT-PCR) analysis
Western blot analysis
Cells were cultured for 6 h with or without Poly(P) and then lysed using cell lysis buffer (Cell Signaling Technology Japan, K.K., Tokyo, Japan). Protein lysates were separated on SDS-polyacrylamide gels (12%) in preparation for western blot analysis using anti-ALP, -OC, -OP, -MMP-3, -DMP-1, and -β-tubulin polyclonal antibodies (sc-271431, sc-30044, sc-10593, sc-6839, sc-5538, sc-13595, sc-6840, sc-30073, and sc-9935, respectively; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Visualization of blotted protein bands was performed using a Multi Gauge-Ver3.X (Fujifilm, Tokyo, Japan).
Measurement of MMP-3 activity
The protocol for measurement of MMP-3 activity has been described previously (27, 28) and is now a commercially available MMP-3 activity assay kit (SensoLyte™ 520 MMP-3 assay kit; AnaSpec, San Jose, CA, USA).
Silencing of the MMP-3 gene by small interfering RNA (siRNA) transfection
Commercially available MMP-3 siRNA (sc-61874, Santa Cruz Biotechnology, Inc.) was transfected into cultured cells using an siRNA reagent system (sc-45064, Santa Cruz Biotechnology, Inc.) according to the manufacturer's protocol. GAPDH siRNA and a control siRNA without known homology to any vertebrate sequence (Thermo Scientific, Lafayette, CO, USA) were used as positive and negative controls, respectively.
Statistical analysis
Data presented in bar graphs are the means ± standard
The majority of Poly(P)-treated DPFCs showed strong ALP expression, whereas control cells had undetectable ALP expression ( Figure 1B-b) . Extensive deposits of calcified matrix were observed in Poly(P)-treated DPFC cultures, whereas calcified matrix was not apparent in control cell cultures ( Figure 1C-b) . Consistently, Poly(P) treatment induced a marked increase in ARS signals ( Figure 1C-a, b) . Taken together, Poly(P) induced osteogenic cells from DPFCs.
Poly(P) induces expression of MMP-3 mRNA and MMP-3 activity in DPFCs
MMP-3 induction by 0.1 mM Poly(P) was assessed using qRT-PCR to measure changes in MMP-3 mRNA expression. The levels of MMP-3 mRNA expression in Poly(P)-treated cells were significantly increased (p < 0.05) at days 3, 5, and 7 of culture ( Figure 2A) . Furthermore, MMP-3 activity was significantly increased (p < 0.01) at days 3, 5, and 7 following treatment of DPFCs with Poly(P) for 24 h ( Figure 2C ). deviation (S.D.) of four to six independent experiments. Statistical significance was assessed using the MannWhitney U-test. A p-value of < 0.05 was considered statistically significant.
Results
Poly(P) induces osteogenic differentiation of DPFCs
We previously analyzed the effect of Poly(P) on cell proliferation of DPFCs, and found that 0.1 mM Poly(P) is an optimal concentration to enhance the cell growth, whereas > 0.2 mM Poly(P) results in potent inhibition of cell proliferation (24) .
To examine whether Poly(P) induced osteogenic characteristics in DPFCs, the cells were cultured in the presence of 0.1 mM Poly(P) for 7 days. Both qRT-PCR and western blotting revealed higher expression of osteogenic differentiation markers ALPL(ALP), BGLAP(OC), SPP1(OP), DSPP, and DMP-1 ( Figure  1A-a, b) . Bone-associated cells also express other MMP proteins including MMP-1, MMP-2, MMP-9, and MMP-13 (29) (30) (31) . However, we found no significant changes in their expression levels in DPFCs treated with 0.1 mM Poly(P) ( Figure 2B ).
MMP-3 activity is precisely regulated at the posttranslational level as a precursor zymogen and by endogenous tissue inhibitors of metalloproteinases (TIMPs) (32) . Although TIMP-2 and TIMP-3 are known to be induced by cytokines (32), we found that TIMP-1, TIMP-2, and TIMP-3 proteins were constitutively expressed in all experimental conditions (data not shown).
siRNA silencing of MMP-3 blocks osteogenic differentiation
To examine whether the up-regulation of MMP-3 expression was associated with osteogenic differentiation, DPFCs were transfected with MMP-3 siRNA or a control scrambled siRNA, and then treated with Poly(P) as described above. Transfection of MMP-3 siRNA abrogated the induction of osteogenic differentiation markers ALPL, BGLAP, SPP1, DSPP, and DMP-1 (p < 0.05, Figure 3A) . Similar changes in the protein levels of each marker were observed in western blot analyses ( Figure 3B) . Furthermore, MMP-3 siRNA blocked induction of ALP activity in Poly(P)-treated cells (p < 0.01, Figure 4A-a, b) . Similarly, the induction of calcification was markedly suppressed (p < 0.05) by Poly(P) treatment of MMP-3-depleted cells ( Figure 4B-a, b) . Collectively, these data show that expression of MMP-3 is required for osteogenic-specific functions in DPFCs.
Discussion
This study indicated that Poly(P)-treated DPFCs can be a novel in vitro model of dental pulp regeneration. Poly(P) at a concentration of 0.1 mM induced MMP-3 expression in DPFCs (Figure 2A ) and led to enhanced DPFC differentiation into osteogenic cells ( Figure 1A -C), although we were unable to precisely determine how many DPFCs had differentiated. However, phenotypic characterization based on calcification and the levels of ALPL (ALP), BGLAP (OC), SPP1 (OP), DSPP, and DMP-1 suggested that a large proportion of the DPFC population differentiated into osteogenic cells ( Figure 1A-a, b) .
We have previously demonstrated that the inflammatory cytokine interleukin-1β or a cytokine mixture induces MMP-3-regulated cell proliferation and suppresses apoptosis in rat DPFCs (19, 20) . Moreover, we previously reported that Poly(P)-induced, MMP-3-mediated proliferation in rat DPFCs is mediated by a Wnt5 signaling cascade (24) . Because we had no definite data on Poly(P)-induced MMP-3 in terms of IGF-1/PI3K/Akt and MAPK signaling pathways (33, 34) in osteogenic differentiation, it remains to be shown. This study is the first report of Poly(P)-induced, MMP-3-mediated responses in the differentiation of DPFCs. Considering the effect of MMP-3 on osteogenic cell differentiation, the present findings suggest that targeting the MMP-3 gene in these osteogenic cells may have a utility in the treatment of suppurative pulpitis. Additionally, Poly(P)-treated DPFCs could serve as an effective model to explore the pathophysiological mechanisms of wound healing. Furthermore, our current evidence suggests that Poly(P)-induced MMP-3 has previously unrecognized physiological functions in wound healing and dental pulp tissue regeneration.
We showed that Poly(P)-induced cells acquired osteogenic-specific functions following differentiation from DPFCs. Poly(P)-treated DPFCs appeared to be predominantly odontoblasts and osteoblasts. A major concern is that we were unable to identify the differentiated cells as odontoblasts because these cells also expressed specific osteoblastic markers including OC and OP. We speculate that DPFCs contain a small population of dental pulp stem cells. Therefore, osteogenic cells may be predominantly derived from dental pulp stem cells, which remains to be elucidated.
The findings presented here support our previous reports (19, 20) and indicate that MMP-3 may have a previously unrecognized physiological function in wound healing and tissue regeneration. Because Poly(P) induces MMP-3-regulated DPFC differentiation into osteogenic cells, the use of Poly(P) represents a potentially superior therapeutic approach for treatment of dental pulp injury instead of applying pulp-capping materials.
